Rachel Lutz

Therapies used to treat C. difficile shouldn’t be chosen based on economic factors but rather on recurrence risk.

This novel procedure offers a management option for recurrent C. diff infections following total abdominal colectomy.

Researchers demonstrate that reducing the dietary intake of sodium is unlikely to reduce the risk of developing MS.

Broad spectrum antibiotics may be to blame for healthcare facility-onset CDI.

Patients diagnosed with the infection included more preventative measures in their daily life after the encounter.

The researchers believe their study is the first to examine C. Diff content on YouTube.

Multiple sclerosis patients may continue to ambulate despite wheelchair or scooter recommendations.

Medicare patients present for readmission for C. difficile in 13% of cases, but outpatient monotherapy may curb readmission rates.

More opportunities for patients washing their hands can reduce the spread of C. difficile.

The introduction of an autoimmune process in the central nervous system may be the culprit of the association between head trauma and MS.

Isolated beds can aid the treatment of C. difficile infected patients.

The study showed 12.7% of the total infected patients had a recurrent infection.

Nursing home communities can theoretically improve health outcomes for patients with antibiotic stewardship programs.

The influenza virus triggered multiple sclerosis relapses in mice models.

Despite declining fatalities, infection rates are climbing, especially among those on Medicare.

There are currently no dietary guidelines for patients with MS and their at-risk relatives. And so far, dietary studies for MS patients have centered on vitamin D and obesity, but not overall diets.

For every hospital admission in the previous year, the odds of C. difficile infection increased by 14%, according to a recent study.

Netherland researchers tracked instances of the C. difficile therapy to as far back as 300 AD, in China.

Researchers from Loyola Medicine retrospectively studied 100 vancomycin taper and pulse treatment patients treated for recurrent C. difficile infection over the span of 5 years.

Netherland researchers compared the efficacy of 4 sporidical disinfectants, in the form of wipes and sprays. Which worked best?

How far can fecal microbial transplants take the cure for C. difficile and other diseases?

The role in this risk may be exacerbated by access of pets and other animals.

Accounting for patients’ calcium intake could one day decrease risk for C. difficile infection, according to a recent study.

Researchers reviewed the current trends in C. difficile treatment with vancomycin in order to shed light on the potential negative effects of cost-related medication non-adherence to vancomycin therapy patients.

FMT has a high cure rate and potentially lower cost compared to other C. difficile therapies. Specifically though, in children, such study results have not been published yet.

In the past decade, the number of individuals who receive solid organ transplants has increased exponentially – something that makes the peri-transplant complications like C. Difficile a common occurrence.

Researchers reviewed nearly 40 million commercially insured patients’ medical records in order to determine how quickly and in what proportions multiple recurrent C. difficile infection rates are growing ahead of C. difficile.

Researchers have correlated asthma, allergic rhinitis, and atopic dermatitis to the condition.

Some hospital readmissions may be avoided for diabetic hypoglycemia and hyperglycemia cases with better follow-up care.